People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Healthtech, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avantis Medical Systems Inc | — | Healthtech | Series B | $47.5M | $56.7M | 2010 |
| Tollpass, LLC | — | Other | Series B | $26.5M | $207.4M | 2023 |
| InterVene, Inc. | — | Other Health Care | Series A | $9.6M | $11.8M | 2015 |
Thomas Fogarty at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Fogarty on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Silverman | 1 | 15 |
| Adam Berger | 1 | 14 |
| Anika Agarwal | 1 | 13 |
| Jay Schmelter | 1 | 6 |
| Evan Ng | 1 | 6 |
| Ben Weinberg | 1 | 4 |
| Richard Randall | 1 | 4 |
| Howard Palefsky | 1 | 4 |
| Adam Berman | 1 | 4 |
| Daniel George | 1 | 4 |
| Scott Dodson | 1 | 3 |
| Michael Mayer | 1 | 3 |
| Joe Biller | 1 | 3 |
| Catherine L. Matthes | 1 | 3 |
| John J. Savarese | 1 | 3 |
| Fletcher Wilson | 1 | 3 |
| John Reed | 1 | 2 |
| Mel Schatz | 1 | 2 |
| Thomas J. Fogarty | 1 | 2 |
| Daniel Turner III | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.